| A | B | C | D | E | F | G | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2 | HECVAT™ Solution Provider Response - Start Here | Version 4.1.6 | |||||||||||||||||||||
3 | Date Completed | 2026-07-09 | |||||||||||||||||||||
4 | Instructions for Solution Providers | ||||||||||||||||||||||
5 | 1. Complete the "Start Here" tab and review the "Required Questions" guidance to find the other sections are required for your product or service. | ||||||||||||||||||||||
6 | 2. Complete the "Organization" tab and the applicable questions in each of the next 5 tabs (Product through Privacy) that apply, based on your answers to the "Required Questions." | ||||||||||||||||||||||
7 | 3. Guidance in column E may change based on your answers to prompt details in "Additional Information." If leaving an answer blank, you must also state why in "Additional Information". | ||||||||||||||||||||||
8 | 4. DO NOT complete any fields in the "Evaluation" sheets or the "Analyst Notes" column. | ||||||||||||||||||||||
9 | 5. Return the completed file to institutions. | ||||||||||||||||||||||
10 | * Denotes critical questions. Critical questions are those deemed most important to institutions by higher education volunteers. | ||||||||||||||||||||||
11 | For full instructions, please visit educause.edu/HECVAT | ||||||||||||||||||||||
12 | General Information | ||||||||||||||||||||||
13 | GNRL-01 | Solution Provider Name | Stanford University | ||||||||||||||||||||
14 | GNRL-02 | Solution Name | Clinical Mind AI | ||||||||||||||||||||
15 | GNRL-03 | Solution Description | Clinical Mind AI is a Stanford University research platform for improving clinical reasoning through AI-simulated clinical cases and physician-patient interactions. It is not a commercial ed-tech product and is not sold as a product; these responses are provided for transparency with institutional collaborators. | ||||||||||||||||||||
16 | GNRL-04 | Solution Provider Contact Name | Clinical Mind AI team | ||||||||||||||||||||
17 | GNRL-05 | Solution Provider Contact Title | Stanford University research project team | ||||||||||||||||||||
18 | GNRL-06 | Solution Provider Contact Email | clinicalmindai@stanford.edu | ||||||||||||||||||||
19 | GNRL-07 | Solution Provider Contact Phone Number | Available upon request through the Clinical Mind AI team. | ||||||||||||||||||||
20 | GNRL-08 | Country of Company Headquarters | United States | ||||||||||||||||||||
21 | GNRL-09 | Employee Work Locations (all) | United States; Stanford University project team and approved collaborators as applicable. | ||||||||||||||||||||
22 | Company Information | Answer | Additional Information | Guidance | Analyst Notes | ||||||||||||||||||
23 | COMP-01 | Do you have a dedicated software and system development team(s) (e.g., customer support, implementation, product management, etc.)?* | Yes | Project engineering, product, implementation, and support functions are handled by the Stanford Clinical Mind AI team and collaborators. | Describe the structure and size of your software and system development teams. (e.g., customer support, implementation, product management, etc.). | ||||||||||||||||||
24 | COMP-02 | Describe your organization’s business background and ownership structure, including all parent and subsidiary relationships. | Clinical Mind AI is operated by Stanford University as a research and educational research platform. It is not a standalone vendor or commercial product for sale. Governance, privacy, and security obligations are handled through Stanford University policies and the relevant research collaboration agreements with participating institutions. | Supplemental context provided for transparency. | Include circumstances that may involve offshoring or multinational agreements. | ||||||||||||||||||
25 | COMP-03 | Have you operated without unplanned disruptions to this solution in the past 12 months? | Yes | Project owner confirms no material security, privacy, uptime, data-loss, or accessibility incidents to disclose as of July 9, 2026. | |||||||||||||||||||
26 | COMP-04 | Do you have a dedicated information security staff or office? | Yes | Stanford University information security and privacy functions apply; Clinical Mind AI is not a separate commercial company. | Describe your information security office, including size, talents, resources, etc. | ||||||||||||||||||
27 | COMP-05 | Use this area to share information about your environment that will assist those who are assessing your company's data security program. | The platform is developed and maintained by the Clinical Mind AI project team with Stanford University oversight. Operational, security, and privacy review responsibilities are handled through Stanford University project governance and institutional processes. | Supplemental context provided for transparency. | Share any details that would help information security analysts assess your solution. | End Table Data | |||||||||||||||||
28 | Required Questions | Answer | Additional Information | Guidance | Analyst Notes | ||||||||||||||||||
29 | REQU-01 | Are you offering a cloud-based product? | Yes | The service is cloud hosted. | DO complete the Product and Infrastructure worksheets | ||||||||||||||||||
30 | REQU-02 | Does your product or service have an interface? | Yes | The current assessed platform has a web interface. No standalone mobile application has been developed or distributed as of July 9, 2026. | DO complete the IT Accessibility worksheet. | ||||||||||||||||||
31 | REQU-03 | Are you providing consulting services? | No | Clinical Mind AI is a research platform, not a consulting service. | DO NOT complete the Consulting section in the Case-Specific worksheet | ||||||||||||||||||
32 | REQU-04 | Does your solution have AI features, or are there plans to implement AI features in the next 12 months? | Yes | AI features are central to simulated patients, generation assistance, parsing/autofill, avatars, and optional feedback. | DO complete the Artificial Intelligence (AI) worksheet | ||||||||||||||||||
33 | REQU-05 | Does your solution process protected health information (PHI) or any data covered by the Health Insurance Portability and Accountability Act (HIPAA)? | No | The platform is not intended to process real PHI or provide clinical care. Any PHI/HIPAA use would require separate Stanford review and approval. | DO NOT complete the HIPAA section in the Case-Specific worksheet | ||||||||||||||||||
34 | REQU-06 | Is the solution designed to process, store, or transmit credit card information? | No | The platform does not process, store, or transmit payment-card data. | DO NOT complete the PCI-DSS section in the Case-Specific worksheet | ||||||||||||||||||
35 | REQU-07 | Does operating your solution require the institution to operate a physical or virtual appliance in their own environment or to provide inbound firewall exceptions to allow your employees to remotely administer systems in the institution's environment? | No | No institution-operated appliance or inbound campus network connection is required. | DO NOT complete the On-Prem section in the Case-Specific worksheet | ||||||||||||||||||
36 | REQU-08 | Does your solution have access to personal or institutional data? | Yes | The platform processes user account, course, institutional, interaction, and educational/research data. | DO complete the Privacy tab | End Table Data | |||||||||||||||||
37 | Note: The "Organization" tab is required for ALL products and services. | ||||||||||||||||||||||
38 | Copyright © 2025 EDUCAUSE | ||||||||||||||||||||||
40 | |||||||||||||||||||||||
41 | |||||||||||||||||||||||
42 | |||||||||||||||||||||||
43 | |||||||||||||||||||||||
44 | |||||||||||||||||||||||
45 | |||||||||||||||||||||||
46 | |||||||||||||||||||||||
47 | |||||||||||||||||||||||
48 | |||||||||||||||||||||||
49 | |||||||||||||||||||||||
50 | |||||||||||||||||||||||
51 | |||||||||||||||||||||||
52 | |||||||||||||||||||||||
53 | |||||||||||||||||||||||
54 | |||||||||||||||||||||||
55 | |||||||||||||||||||||||
56 | |||||||||||||||||||||||
57 | |||||||||||||||||||||||
58 | |||||||||||||||||||||||
59 | |||||||||||||||||||||||
60 | |||||||||||||||||||||||
61 | |||||||||||||||||||||||
62 | |||||||||||||||||||||||
63 | |||||||||||||||||||||||
64 | |||||||||||||||||||||||
65 | |||||||||||||||||||||||
66 | |||||||||||||||||||||||
67 | |||||||||||||||||||||||
68 | |||||||||||||||||||||||
69 | |||||||||||||||||||||||
70 | |||||||||||||||||||||||
71 | |||||||||||||||||||||||
72 | |||||||||||||||||||||||
73 | |||||||||||||||||||||||
76 | |||||||||||||||||||||||
77 | |||||||||||||||||||||||
78 | |||||||||||||||||||||||
79 | |||||||||||||||||||||||
80 | |||||||||||||||||||||||
81 | |||||||||||||||||||||||
82 | |||||||||||||||||||||||
83 | |||||||||||||||||||||||
84 | |||||||||||||||||||||||
85 | |||||||||||||||||||||||
86 | |||||||||||||||||||||||
87 | |||||||||||||||||||||||
88 | |||||||||||||||||||||||
89 | |||||||||||||||||||||||
90 | |||||||||||||||||||||||
91 | |||||||||||||||||||||||
92 | |||||||||||||||||||||||
93 | |||||||||||||||||||||||
94 | |||||||||||||||||||||||
95 | |||||||||||||||||||||||
96 | |||||||||||||||||||||||
97 | |||||||||||||||||||||||
98 | |||||||||||||||||||||||
99 | |||||||||||||||||||||||
100 | |||||||||||||||||||||||
101 | |||||||||||||||||||||||
102 | |||||||||||||||||||||||
103 | |||||||||||||||||||||||
104 |